Fondaparinux is a synthetic pentasaccharide that produces irreversible, antithrombin-mediated inhibition of Factor Xa. It has high bioavailability following subcutaneous injection and has a ...
Main Objectives. This was a randomized, double-blind trial of fondaparinux in patients with STEMI. The primary objective of the study was to evaluate the impact of fondaparinux as an anticoagulant ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback